NeurAxis Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Revenue	2.46	2.68	2.72	2.18
Revenue Growth (YoY)	-8.37%	-1.34%	24.82%	-
Cost of Revenue	0.3	0.3	0.47	0.48
Gross Profit	2.16	2.39	2.25	1.7
Selling, General & Admin	8.65	5.53	5.02	5.4
Research & Development	0.17	0.23	0.2	0.17
Operating Expenses	8.82	5.76	5.22	5.57
Operating Income	-6.66	-3.37	-2.97	-3.87
Interest Expense / Income	0.48	0.32	0.04	0
Other Expense / Income	7.49	1.09	0.02	-0.14
Pretax Income	-14.63	-4.78	-3.03	-3.73
Net Income	-14.63	-4.78	-3.03	-3.73
Shares Outstanding (Basic)	3	2	2	2
Shares Outstanding (Diluted)	3	2	2	2
Shares Change	62.35%	1.79%	-	-
EPS (Basic)	-4.50	-2.77	-1.92	-2.20
EPS (Diluted)	-4.50	-2.77	-1.92	-2.20
Free Cash Flow	-6.77	-2.36	-2.24	-4.17
Free Cash Flow Per Share	-2.08	-1.18	-1.14	-2.12
Gross Margin	87.67%	88.94%	82.81%	77.93%
Operating Margin	-270.91%	-125.61%	-109.14%	-177.54%
Profit Margin	-594.57%	-178.05%	-111.27%	-170.91%
Free Cash Flow Margin	-275.03%	-87.87%	-82.16%	-191.13%
EBITDA	-14.08	-4.4	-2.93	-3.67
EBITDA Margin	-572.28%	-163.80%	-107.73%	-168.37%
Depreciation & Amortization	0.07	0.06	0.06	0.06
EBIT	-14.15	-4.46	-2.99	-3.73
EBIT Margin	-575.20%	-166.18%	-109.92%	-170.91%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).